Macrophages are among the most versatile immune cells in biology. They safeguard tissue integrity, eliminate pathogens, clear apoptotic debris, remodel extracellular matrix, and coordinate repair. At the same time, when their recruitment, activation, or differentiation becomes dysregulated, macrophages can become powerful drivers of chronic inflammation, immune suppression, fibrosis, tissue destruction, and therapeutic resistance. Across cancers, autoimmune disorders, cardiovascular diseases, chronic infections, neurodegeneration, immunodeficiency, and wound-healing disorders, disease-associated macrophages sit at the intersection of pathogenesis and translation.

At Creative Biolabs, we provide a comprehensive macrophages in diseases solution set designed to help researchers decode disease-specific macrophage programs, build physiologically relevant models, screen macrophage-targeted interventions, and generate decision-driving preclinical data.

Overview of Macrophages in Human Diseases

Macrophages are not a single uniform cell type. Depending on tissue context, they may arise from embryonic precursors, long-lived tissue-resident populations, or bone-marrow-derived monocytes that enter tissues during homeostasis or inflammation. Disease perturbs this balance and generates macrophage states shaped by cytokines, hypoxia, metabolic pressure, matrix composition, microbial ligands, dying cells, and interactions with stromal and immune compartments. As a result, macrophages in diseased tissues display remarkable heterogeneity in origin, localization, transcriptional wiring, effector function, and therapeutic vulnerability.

Fig. 1 Macrophage polarization spectrum during inflammation.^1,2

The traditional M1/M2 framework remains useful for conceptualizing inflammatory versus reparative tendencies, but it is insufficient to capture the full continuum of disease-associated macrophage states. In real tissues, macrophages often display mixed or transitional phenotypes with simultaneous inflammatory, suppressive, metabolic, and remodeling features. This is particularly evident in tumors, autoimmune lesions, atherosclerotic plaques, tuberculous granulomas, and chronic wounds. Therefore, disease-relevant macrophage research increasingly relies on multidimensional profiling rather than binary classification alone.

Macrophages can be interrogated as biomarkers, stratification tools, pharmacodynamic readouts, therapeutic targets, or even engineered therapeutic vehicles. Below is an overview of the major disease classes.

• Macrophages in Cancers
• Macrophages in Autoimmune Diseases
• Macrophages in Cardiovascular Diseases
• Macrophages in Tuberculosis
• Macrophages and Alzheimer's Disease
• Macrophages in Primary Immunodeficiency Disease
• Macrophages in Wound Healing

Our Service Portfolio

Creative Biolabs offers a disease-centered macrophage research solution built around three principles: biological relevance, mechanism-driven interpretation, and translation-ready data generation. We tailor every study to the disease context, tissue niche, and therapeutic hypothesis of your program.

Disease-Relevant Model Library

We build macrophage models that reflect the diversity of pathological settings rather than relying on oversimplified stimulation alone. Available systems include:

• Human PBMC-derived monocyte-to-macrophage differentiation systems
• Donor-diverse primary macrophages from blood, bone marrow, or disease-associated tissues
• iPSC-derived macrophage platforms for reproducibility and genetic control
• Established myeloid cell lines for high-throughput screening
• Mouse macrophage systems including BMDMs and peritoneal macrophages
• Disease-specific co-culture models with fibroblasts, epithelial cells, endothelial cells, tumor cells, neurons, glia, or infected target cells

We also incorporate disease microenvironment modules such as hypoxia, lactic acidosis, immune complexes, oxidized lipids, myelin debris, bacterial challenge, apoptotic-cell burden, iron loading, fibrotic matrix, and cytokine cocktails relevant to the target indication.

Polarization, Phenotyping, and State Identification

We provide robust platforms to generate and validate macrophage states linked to disease progression or resolution. Readouts may include:

• Surface-marker phenotyping by multi-parameter flow cytometry
• Cytokine and chemokine profiling by ELISA or multiplex analysis
• Transcriptomic and pathway-level analysis
• Metabolic profiling, including ECAR/OCR and mitochondrial stress testing
• Phospho-signaling evaluation
• Phagocytosis and efferocytosis assays
• Migration, chemotaxis, adhesion, and invasion assays
• Antigen-presentation and co-stimulatory function assessment

For studies requiring higher dimensionality, we also support immunofluorescence, IHC, spatially resolved analysis, single-cell-compatible sample preparation, and targeted or broad multi-omics workflows.

Functional Disease Modules

Macrophage biology is best understood in context. We therefore offer disease-relevant functional modules such as:

• Macrophage–tumor-cell and macrophage–stromal interaction assays
• Macrophage–fibroblast cross-talk analysis
• Osteoclastogenesis and osteoimmunology panels
• Endothelial activation and transendothelial migration assays
• Infected-macrophage pathogen survival and clearance models
• Amyloid or debris uptake assays for neurodegenerative studies
• Wound-healing migration, matrix-remodeling, and repair assays

Macrophage-Targeted Screening and Therapeutic Evaluation

We support screening and profiling of a wide range of modalities, including small molecules, antibodies, cytokines, biologics, nucleic-acid payloads, nanoparticles, liposomes, engineered exosomes, and cell-based interventions. Programs can be designed to evaluate:

• Cytokine blockade
• Recruitment blockade
• Depletion strategies
• Reprogramming toward pro-resolving states
• Metabolic rewiring
• Enhancement of phagocytosis or pathogen clearance
• Targeted drug delivery to macrophage-enriched lesions

Workflow

To accelerate disease-focused macrophage programs, we use a modular but highly customizable workflow.

Therapeutic Strategies Targeting Macrophages in Diseases

Because macrophages contribute to disease through diverse mechanisms, effective interventions may target them in very different ways depending on indication.

Related Products

Curated, assay-ready tools that plug into cancer macrophage workflows. (Availability may vary by project design.)

Scientific Resources

Q & A

Q: Which macrophage source is best for disease studies?

A: The answer depends on your goal. Primary human macrophages often provide the strongest biological relevance and donor-specific insight. iPSC-derived macrophages offer reproducibility and genetic control. Cell lines are useful for rapid screening and assay development.

Q: Can you build disease-specific macrophage models rather than using standard M1/M2 stimulation only?

A: Yes. We routinely design microenvironment-informed systems using disease-relevant cytokines, conditioned media, matrix cues, hypoxia, oxidized lipids, immune complexes, pathogen challenge, or co-culture partners to better reproduce in vivo macrophage states.

Q: Do you support macrophage-focused screening of drugs, antibodies, or delivery systems?

A: Yes. We support screening and profiling of small molecules, biologics, nanoparticles, nucleic-acid payloads, exosomes, and macrophage-targeted delivery approaches using phenotype, function, signaling, and disease-specific endpoints.

Q: Can you analyze macrophage populations from our own animal or human samples?

A: Yes. We can work with tissue, blood, lavage, fluid, or dissociated-cell samples, depending on project design and sample quality requirements. Available analyses may include flow cytometry, cytokine profiling, imaging-based characterization, and downstream molecular profiling.

Q: How do I start a project?

A: Share your disease indication, study objective, preferred model system, and key endpoints. Our scientists will then propose a customized workflow, timeline, and data package tailored to your program.

References

1. Brancewicz, Jan, et al. "The multifaceted role of macrophages in biology and diseases." International journal of molecular sciences 26.5 (2025): 2107. https://doi.org/10.3390/ijms26052107
2. Distributed under Open Access license CC BY 4.0, without modification.